No definition available.
Other congenital malformations of urinary system
Q17_OTHER_CONGEN_MALFO_URINARY_SYSTEM
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
177 |
4. Check minimum number of eventsNone |
177 |
5. Include endpointsNone |
177 |
6. Filter based on genotype QC (FinnGen only) |
177 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_URINARY_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q6[0-4]
- Name in latin
- Aliae malformationes congenitae systematis urinarii
Similar endpoints
↥List of similar endpoints to
Other congenital malformations of urinary system
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of the urinary system
- Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2018 | 615 | 1402 |
| Only index persons | 1583 | 486 | 1097 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.02 | 0.04 |
| Only index persons | 0.03 | 0.02 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 7.52 | 12.17 | 5.45 |
| Only index persons | 13.99 | 21.46 | 10.68 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 177 | 67 | 110 |
| Unadjusted period prevalence (%) | 0.04 | 0.02 | 0.05 |
| Median age at first event (years) | 24.51 | 41.21 | 14.34 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 157
- Matched controls
- 1570
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UKC02
NOMESCO Finland
Cystoscopy
37.0
70.3
95
62
Q64.2
ICD-10 Finland
Congenital posterior urethral valves
+∞
53.2
48
*
Q64.4
ICD-10 Finland
Malformation of urachus
+∞
50.8
46
*
J01EA01
ATC
trimethoprim; systemic
9.6
31.7
76
139
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
19.2
29.5
46
33
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
13.6
29.4
54
58
N18.8
ICD-10 Finland
Other chronic renal failure
35.4
28.2
36
13
XKD00
NOMESCO Finland
Uroflowmetry
11.0
28.0
58
79
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
28.8
26.7
36
16
Z94.0
ICD-10 Finland
Kidney transplant status
27.7
25.7
35
16
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
30.6
25.7
34
14
A11CC03
ATC
alfacalcidol; systemic
21.1
23.6
35
21
127
Kela drug reimbursment
Transplant complication
20.1
23.2
35
22
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
37.4
22.4
28
9
XKC03
NOMESCO Finland
Water cystometry
23.8
21.9
31
16
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
8.9
20.6
47
72
A12AA04
ATC
calcium carbonate; oral
42.1
20.5
25
7
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
20.3
20.1
30
18
L04AA06
ATC
mycophenolic acid; systemic
20.6
19.6
29
17
WX408
NOMESCO Finland
General anesthesy, balanced
4.9
18.9
84
299
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
38.1
18.6
23
7
KCD40
NOMESCO Finland
Excision of urachus
+∞
18.1
17
*
Q62.7
ICD-10 Finland
Congenital vesico-uretero-renal reflux
+∞
18.1
17
*
1530
FHL
Urethrocystoscopy
107.4
18.0
19
*
204
Kela drug reimbursment
Leukemia lymphatica
24.5
18.0
25
12
KC1JB
NOMESCO Finland
Miktiocystography with X-ray
+∞
17.0
16
*
Q64.1
ICD-10 Finland
Exstrophy of urinary bladder
+∞
17.0
16
*
KH1EE
NOMESCO Finland
Urologic ultrasound examination
53.6
16.4
19
*
ZXE00
NOMESCO Finland
One hour or less
4.1
15.9
94
418
B03XA01
ATC
erythropoietin; parenteral
35.7
15.2
19
6
J01MA02
ATC
ciprofloxacin; systemic
4.3
14.9
69
241
KDD52
NOMESCO Finland
Urethroscopic excision of urethral valve
+∞
14.8
14
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
22.7
14.2
20
10
ZXE20
NOMESCO Finland
More than three and less than five hours
5.5
14.1
45
106
L04AD01
ATC
ciclosporin; systemic
13.3
13.9
24
21
137
Kela drug reimbursment
Uraemia requiring dialysis
20.6
13.8
20
11
Q64.0
ICD-10 Finland
Epispadias
+∞
13.7
13
*
Q64.9
ICD-10 Finland
Congenital malformation of urinary system, unspecified
+∞
13.7
13
*
Q64.8
ICD-10 Finland
Other specified congenital malformations of urinary system
+∞
13.7
13
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
15.8
13.7
22
16
ZXE10
NOMESCO Finland
More than one and less than three hours
3.8
13.6
80
338
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
12.7
13.6
24
22
ZXD10
NOMESCO Finland
Scheduled procedure
3.7
13.3
84
375
H02AB04
ATC
methylprednisolone; systemic
5.5
13.0
41
94
L04AX01
ATC
azathioprine; systemic
8.7
12.9
28
38
J01XE01
ATC
nitrofurantoin; oral
23.6
12.3
17
8
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
5.6
12.3
38
85
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.5
12.2
49
145
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.7
12.2
32
58
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
21.0
11.9
17
9
G04BD04
ATC
oxybutynin; oral, transdermal
13.3
11.7
20
17
Q64.38
ICD-10 Finland
Other atresia and stenosis of urethra and bladder neck
+∞
11.6
11
*
7536A
ICD-9 Finland
Congenital anomalies of urinary system, Atresia and stenosis of urethra and bladder neck[OBSTRUCTIO URETHRAE ET COLLI VESICAE CONGENITA]
+∞
11.6
11
*
Q62.0
ICD-10 Finland
Congenital hydronephrosis
+∞
11.6
11
*
N18.0
ICD-10 Finland
End-stage renal disease
18.9
11.5
17
10
G04AC01
ATC
NA
18.9
11.5
17
10
V03AE01
ATC
polystyrene sulfonate; oral
38.1
11.5
14
*
TK800
NOMESCO Finland
Hemodialysis
15.5
11.3
18
13
Z49.1
ICD-10 Finland
Extracorporeal dialysis
17.1
11.1
17
11
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
46.9
11.1
13
*
L04AA01
ATC
[U] ciclosporin; systemic
19.6
11.0
16
9
Z3226
NOMESCO Finland
Physiotherapist
3.7
10.6
55
201
TPH04
NOMESCO Finland
Cathetrisation of vein
3.8
10.6
51
176
Q64.34
ICD-10 Finland
Congenital prolapse of: urinary meatus
+∞
10.5
10
*
Q64.31
ICD-10 Finland
Congenital stricture of: urethra
+∞
10.5
10
*
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
35.2
10.5
13
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
11.8
10.1
18
17
K06.18
ICD-10 Finland
Another gingival hyperplasia
28.1
10.0
13
5
5AB14
NOMESCO Finland
NA
58.7
9.8
11
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
7.6
9.5
22
33
KBJ00
NOMESCO Finland
Cutaneous ureterostomy
+∞
9.5
9
*
Q62.2
ICD-10 Finland
Congenital megaloureter
+∞
9.5
9
*
ZX120
NOMESCO Finland
Intravenous
5.2
9.3
29
65
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
20.1
9.1
13
7
ZXD05
NOMESCO Finland
Urgent procedure
3.0
8.9
64
291
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
9.1
8.9
18
22
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.4
8.8
50
192
TKC20
NOMESCO Finland
Catheterisation of bladder
8.2
8.8
19
26
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
13.8
8.6
14
11
H02AB09
ATC
hydrocortisone; systemic
6.4
8.5
22
39
KCH96
NOMESCO Finland
Other reconstructive operation on bladder
+∞
8.4
8
*
R50.9
ICD-10 Finland
Fever, unspecified
3.5
8.2
43
154
RD210
NOMESCO Finland
NA
7.3
8.2
19
29
TKC22
NOMESCO Finland
Catheterisation instruction
35.4
8.2
10
*
Z3231
NOMESCO Finland
Registered nurse
2.8
8.2
72
366
Z49.0
ICD-10 Finland
Preparatory care for dialysis
23.5
8.1
11
5
XF602
NOMESCO Finland
Bloodpressure monitoring
10.2
8.0
15
16
R4110
NOMESCO Finland
Physiotherapy
2.9
7.9
57
256
205
Kela drug reimbursment
Chronic hypertension
3.7
7.9
36
117
B05DA
ATC
Isotonic solutions
16.1
7.8
12
8
5901A
ICD-9 Finland
Infections of kidney, Acute pyelonephritis
47.4
7.8
9
*
602
Kela drug reimbursment
Children's severe malnutrition
9.1
7.5
15
18
ZXD20
NOMESCO Finland
Day surgery
3.7
7.5
33
104
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
7.2
7.3
17
26
Q64.30
ICD-10 Finland
Congenital bladder neck obstruction
+∞
7.3
7
*
Q64.6
ICD-10 Finland
Congenital diverticulum of bladder
+∞
7.3
7
*
B07.9
ICD-10 Finland
Verruca simplex
6.6
7.3
18
30
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
31.6
7.2
9
*
B03XA02
ATC
darbepoetin alfa; parenteral
12.9
7.2
12
10
TPH07
NOMESCO Finland
Cathetrisation of artery
4.7
7.2
24
58
J01CA08
ATC
pivmecillinam; oral
2.8
7.2
56
263
R31
ICD-10 Finland
Unspecified haematuria
5.3
7.2
21
44
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
14.7
7.0
11
8
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
14.7
7.0
11
8
B05DB
ATC
Hypertonic solutions
14.7
7.0
11
8
WX402
NOMESCO Finland
General anaesthesia
3.1
6.9
41
159
C08CA01
ATC
amlodipine; oral
3.1
6.9
41
160
TKC52
NOMESCO Finland
Patient education concerning pelvic floor contraction exercises
72.7
6.5
7
*
4AA09
NOMESCO Finland
NA
72.7
6.5
7
*
5850B
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA CUM URAEMIA]
72.7
6.5
7
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
7.6
6.4
14
20
Q60.0
ICD-10 Finland
Renal agenesis, unilateral
+∞
6.3
6
*
75360
ICD-8 Finland
Congenital anomalies of urinary system, Valvula urethrae cum hydronephrosi
+∞
6.3
6
*
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
+∞
6.3
6
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
6.2
64
345
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
13.2
6.2
10
8
C08CA02
ATC
felodipine; oral
5.5
6.1
17
34
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
33
33
12.06
30.10
14.5
8.8
iu/ml
104.8
744.4
—
6
8
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
23
19
13.76
23.42
2.4
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
71
213
4.90
22.73
8.1
2.5
e6/l
1.6
0.7
0.69
52
118
(3049717) Cytology report of Urine Cyto stain
23
20
13.07
22.70
1.9
3.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
68
198
4.95
22.57
8.3
2.6
e6/l
2.4
1.9
0.14
49
103
(3000850) Epithelial cells [#/volume] in Urine
78
261
4.56
21.54
10.3
2.2
e6/l
4.2
4.4
0.08
78
235
(3030467) Casts [#/volume] in Urine by Automated count
92
352
4.36
21.13
12.1
2.6
e6/l
0.3
0.2
0.45
82
260
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
104
435
4.37
21.11
14.1
2.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
93
359
4.35
21.09
11.9
2.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
78
265
4.47
21.03
6.9
2.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
97
390
4.29
20.71
13.4
2.7
e6/l
33.3
26.1
0.18
88
295
(3026782) Osmolality of Urine
72
236
4.46
20.25
8.4
2.3
mosm/kgh2o
526.5
602.5
1.94
72
202
(3023520) Reticulocytes [#/volume] in Blood
43
97
5.53
18.99
3.3
3.9
e9/l
65.4
73.4
0.76
33
72
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
21
21
11.21
18.85
1.5
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
101
447
3.93
18.19
16.0
3.3
e6/l
164.4
49.0
0.96
91
308
(3012544) pH of Venous blood
54
154
4.61
17.97
22.0
8.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
53
154
4.49
17.15
22.3
8.6
mmol/l
0.3
1.3
1.21
48
120
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
21
24
9.79
17.13
3.0
2.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
29
49
6.88
17.12
4.7
1.6
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
29
50
6.74
16.79
4.4
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
78
310
3.71
16.11
16.6
3.3
ph
7.4
7.4
1.39
14
50
(3026493) Urate [Moles/volume] in Serum or Plasma
71
270
3.72
15.59
5.6
3.4
umol/l
4778.8
6103.0
0.10
66
241
(3042733) HLA Ab [Presence] in Serum
18
5
39.77
14.75
4.9
2.8
—
—
—
0
0
(3015736) pH of Urine
98
474
3.39
14.47
7.8
3.0
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
20
27
8.22
14.28
2.3
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
49
158
3.91
13.50
26.7
9.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
137
842
3.77
13.16
13.5
3.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
28
61
5.26
12.62
3.6
1.4
u/ml
177.4
200.7
0.21
23
32
(3021601) Nitrite [Presence] in Urine by Test strip
108
586
3.16
12.57
12.6
4.4
estimate
0.0
0.0
0.00
23
118
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
28
63
5.09
12.16
3.5
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
108
596
3.08
12.02
9.1
3.2
estimate
0.0
0.0
0.00
24
110
(3035350) Ketones [Presence] in Urine by Test strip
107
590
3.06
11.88
9.1
3.2
estimate
0.0
0.0
0.00
24
112
(3048929) Epstein Barr virus Ab [Presence] in Serum
35
102
4.03
10.97
3.2
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
14
9.94
10.90
17.3
2.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
74
347
2.95
10.82
8.1
3.5
mmol/l
7.5
8.7
1.40
69
309
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
103
580
2.86
10.61
37.1
7.9
mmol/l
1.2
1.2
0.56
95
505
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
97
535
2.80
10.31
4.9
3.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
63
281
2.93
9.96
7.3
3.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
29
82
4.03
9.41
3.2
3.1
ml/min/173m2
50.8
80.0
2.10
12
34
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
42
153
3.29
9.37
35.1
10.0
mmol/l
24.5
25.0
0.41
42
153
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
94
541
2.57
8.75
8.1
2.6
nmol/l
73.4
73.0
0.05
89
494
(3042936) Bacteria identified in Isolate by Culture
43
167
3.08
8.57
3.0
2.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
42
165
3.03
8.18
2.5
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
62
300
2.64
8.16
1.9
1.8
mmol/l
1.5
1.3
0.46
57
268
(3023368) Bacteria identified in Blood by Culture
58
272
2.68
8.12
10.0
4.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
76
407
2.52
8.09
5.0
6.1
inr
1.1
1.1
0.14
16
128
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
59
280
2.66
8.06
3.8
2.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
71
374
2.50
7.77
9.3
3.3
mmol/l
2.4
2.4
1.53
65
342
(3044640) Blood type and Crossmatch panel - Blood
67
357
2.41
7.03
4.1
2.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
49
227
2.60
6.91
7.6
3.3
mg/l
112.7
55.6
0.96
41
151
(4035726)
28
95
3.31
6.91
1.8
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
38
155
2.85
6.85
26.0
5.6
mmol/l
1.2
1.3
0.04
30
105
(40758558) Short blood count panel - Blood
70
387
2.34
6.70
10.5
8.1
—
—
—
0
0
(3009343) pH of Capillary blood
38
158
2.79
6.60
26.6
5.5
ph
7.4
7.4
—
8
6
(3028626) Oxygen [Partial pressure] in Capillary blood
31
115
3.06
6.60
29.4
5.2
kpa
10.2
9.7
0.76
31
106
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
10
7
15.03
6.48
4.9
8.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
82
492
2.24
6.40
15.4
8.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
34
137
2.83
6.24
25.9
5.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
40
176
2.64
6.21
4.0
5.5
umol/l
4.4
8.6
1.38
34
151
(3020682) Albumin/Creatinine [Ratio] in Urine
48
235
2.43
5.95
8.6
3.9
mg/mmol
21.2
7.4
1.46
38
154
(3041096) Erythrocytes [Presence] in Urine by Automated
60
330
2.24
5.66
8.5
2.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
29
4.76
5.61
1.2
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
21
5.52
5.60
17.4
2.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
75
456
2.12
5.46
9.2
3.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
13
30
4.60
5.39
1.8
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
13
30
4.60
5.39
1.8
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
45
223
2.36
5.39
3.3
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
15
39
4.11
5.38
1.8
1.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
109
767
2.10
5.32
14.4
7.5
e9/l
2.1
2.1
0.00
100
680
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
153
1236
2.75
5.32
5.4
3.8
mmol/l
2.8
2.8
0.39
143
1160
(3000494) Fungus identified in Specimen by Culture
34
149
2.59
5.28
1.6
1.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
106
740
2.08
5.26
14.3
7.6
e9/l
0.0
0.0
0.71
93
638
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
0
+∞
5.23
5.8
0.0
mmol/l
5.1
—
—
5
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
138
1073
2.30
5.08
5.5
4.4
mmol/mol
36.9
38.5
1.96
131
1022
(3001604) Monocytes [#/volume] in Blood
105
738
2.04
5.03
14.5
7.6
e9/l
0.6
0.6
0.83
93
636
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
14
37
4.02
4.92
1.3
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
20
68
3.19
4.89
1.9
2.4
g/l
66.8
66.2
0.12
20
63
(1616796) Gas panel - Central venous blood
11
24
4.82
4.85
17.2
3.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
106
758
1.99
4.72
15.8
8.1
e9/l
0.2
0.2
0.04
97
672
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
30
4.22
4.51
2.6
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
51
285
2.11
4.50
2.8
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
145
1177
2.28
4.40
4.6
3.2
mmol/l
1.4
1.3
0.93
135
1105
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
6
12.07
4.31
1.1
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
6
12.07
4.31
1.1
1.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
20
74
2.92
4.25
2.9
6.4
%
98.0
90.9
0.66
20
74
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
35
172
2.29
4.22
3.5
2.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
51
293
2.04
4.15
2.5
2.5
mg/l
3.0
3.0
0.01
45
263
(3013650) Neutrophils [#/volume] in Blood by Automated count
113
848
1.92
4.13
16.3
10.8
e9/l
3.9
3.9
0.09
103
727
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
28
126
2.45
4.09
3.8
1.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
95
676
1.87
4.08
19.1
9.3
e9/l
0.0
0.0
0.78
77
537
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
28
4.12
4.04
2.5
1.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
28
4.12
4.04
1.6
2.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
25
108
2.53
3.98
16.2
11.0
mmol/l
1.1
1.5
1.22
25
102
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
148
1229
2.25
3.96
5.3
3.5
mmol/l
1.3
1.4
3.87
139
1151
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
66
2.92
3.89
2.1
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
148
1235
2.21
3.81
5.3
3.6
mmol/l
4.5
4.7
1.20
142
1163
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
32
158
2.25
3.80
2.7
2.8
mmol/l
2.4
2.4
0.47
25
136
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
18
67
2.88
3.79
15.9
4.0
mmol/l
1.3
1.2
3.16
18
59
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
38
203
2.11
3.72
3.2
3.2
ng/l
195.6
450.7
0.86
25
130
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
58
362
1.90
3.67
3.3
2.5
u/l
63.9
53.1
1.43
58
340
(3013707) Erythrocyte sedimentation rate by Westergren method
122
960
1.87
3.62
7.5
4.0
mm/h
12.9
8.1
2.34
113
894
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
26
122
2.33
3.47
3.7
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
58
368
1.86
3.46
3.3
2.0
—
—
—
0
0
(44790049)
10
27
3.87
3.40
2.8
1.9
—
—
—
0
0
(44806118)
10
27
3.87
3.40
2.8
1.9
—
—
—
0
0
(44790048)
10
27
3.87
3.40
2.8
1.9
—
—
—
0
0
(44790047)
10
27
3.87
3.40
2.8
1.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
97
725
1.75
3.29
12.7
5.5
mmol/l
6.0
6.5
2.93
92
676
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
14
49
3.02
3.27
9.9
8.4
%
1.1
1.4
0.74
14
49
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
21
92
2.46
3.25
3.8
3.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
12
39
3.23
3.15
15.1
3.4
%
61.5
61.9
0.02
12
39
(3024928) Oxygen saturation in Venous blood
9
21
4.46
3.04
4.9
16.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
47
2.91
2.88
2.9
2.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
8
18
4.60
2.83
5.0
17.2
%
82.2
73.9
—
8
18
(3010015) Selenium [Moles/volume] in Serum or Plasma
5
6
8.53
2.76
2.0
2.7
umol/l
1.5
1.2
—
5
6
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
55
366
1.73
2.72
1.9
1.8
pmol/l
101.5
100.2
0.07
27
191
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
19
4.36
2.71
1.3
1.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
44
275
1.80
2.70
4.2
4.1
ug/l
1.5
1.9
0.69
39
246
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
45
286
1.77
2.60
2.4
2.7
mg/l
1.5
0.9
0.63
33
213
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
136
1156
1.76
2.58
21.2
9.5
ml/min/173m2
83.5
93.5
3.46
112
889
(3019150) Specific gravity of Urine by Refractometry
45
287
1.76
2.57
8.7
3.5
kg/l
1.0
1.0
—
7
37
(4062490)
6
11
5.60
2.56
1.5
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
23
117
2.11
2.54
1.7
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
57
2.58
2.52
1.6
1.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
8
21
3.94
2.49
15.0
3.3
kpa
11.1
8.8
—
8
21
(3013290) Carbon dioxide [Partial pressure] in Blood
8
21
3.94
2.49
20.1
3.3
kpa
4.9
5.3
—
8
21
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
15
64
2.47
2.46
2.9
6.1
%
240.7
168.4
1.39
15
64
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
10
34
3.06
2.45
2.0
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
12
5.13
2.42
2.7
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
12
5.13
2.42
1.7
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
25
134
2.01
2.42
1.5
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
23
120
2.05
2.39
4.3
3.0
g/l
9.3
9.8
0.21
23
110
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
18
85
2.24
2.38
2.7
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
163
1480
2.28
2.36
25.1
9.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
17
79
2.27
2.33
1.2
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
47
2.67
2.32
3.1
2.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
23
3.59
2.30
1.9
2.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
20
101
2.11
2.26
12.8
2.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
29
3.21
2.26
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
5
9
5.68
2.23
1.2
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
9
5.68
2.23
1.2
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
47
316
1.66
2.20
12.1
3.5
estimate
0.0
0.0
0.00
19
112
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
30
3.10
2.18
1.3
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
7
19
3.79
2.17
6.6
3.1
%
15.7
18.1
—
7
9
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
37
2.80
2.14
2.2
1.8
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
16
76
2.22
2.10
2.2
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
20
106
2.00
2.00
7.1
5.0
%
0.4
0.9
—
10
31
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
51
2.45
2.00
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
51
2.45
2.00
1.1
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
19
99
2.03
1.99
7.3
5.1
%
0.0
0.3
—
8
27
(3021440) Promyelocytes/100 leukocytes in Blood
19
99
2.03
1.99
7.2
5.2
%
0.0
0.1
—
10
28
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
21
3.43
1.98
2.0
2.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
52
2.40
1.92
1.1
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
13
59
2.30
1.89
25.2
11.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
34
218
1.69
1.89
4.2
4.0
%
22.6
21.6
0.10
14
95
(4094501)
6
17
3.61
1.85
1.0
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
19
102
1.97
1.84
6.4
4.7
%
0.1
0.5
—
7
25
(3008037) Lactate [Moles/volume] in Venous blood
5
12
4.25
1.83
2.0
3.9
mmol/l
1.3
1.4
—
5
12
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
12
4.25
1.83
1.8
3.5
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
5
12
4.25
1.83
2.0
3.9
mmol/l
6.0
7.4
—
5
12
(3019309) Folate [Moles/volume] in Red Blood Cells
24
140
1.83
1.83
1.5
1.8
nmol/l
1152.2
1259.4
0.21
17
111
(3023511) Choriogonadotropin [Units/volume] in Urine
9
35
2.65
1.83
1.2
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
18
3.41
1.76
1.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
24
2.99
1.74
2.7
1.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
24
2.99
1.74
2.0
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
13
3.92
1.72
4.2
23.3
%
13.2
11.8
—
5
13
(1761482) Bacteria [#/volume] in Urine by Culture
6
19
3.23
1.67
5.3
4.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
25
2.87
1.66
5.9
3.4
e9/l
3.2
4.1
—
7
25
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
25
2.87
1.66
6.4
3.6
%
45.6
56.0
—
7
25
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
25
2.87
1.66
2.3
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
97
805
1.45
1.66
3.4
2.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
56
2.23
1.65
1.6
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
11
50
2.28
1.60
3.4
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
15
3.40
1.53
1.0
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
18
102
1.85
1.51
1.3
1.4
u/ml
228.4
450.1
0.40
18
96
(3036481) Cortisol [Moles/volume] in Serum or Plasma
25
157
1.69
1.51
4.7
2.2
nmol/l
211.9
344.1
4.86
25
147
(3000330) Specific gravity of Urine by Test strip
9
37
2.51
1.50
6.8
3.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
9
39
2.38
1.45
5.3
2.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
129
1145
1.47
1.45
4.5
3.4
mmol/l
5.6
5.7
1.33
122
1066
(3021879) Hepatitis B virus core Ab [Presence] in Serum
22
135
1.72
1.44
2.1
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
155
1433
1.66
1.41
34.3
11.4
mg/l
19.1
21.3
0.52
133
1006
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
68
1.98
1.37
1.5
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
47
2.20
1.36
2.3
2.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
25
162
1.63
1.35
3.6
2.5
ug/l
0.5
0.7
2.11
15
86
(40760892) CBC W Ordered Manual Differential panel - Blood
43
318
1.47
1.31
11.3
4.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
38
2.16
1.20
3.0
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
31
2.31
1.11
2.1
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
41
2.00
1.10
1.1
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
29
0.00
0.98
0.0
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
36
1.98
0.98
4.0
2.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
36
1.98
0.98
1.1
3.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
151
1415
1.46
0.97
35.1
12.7
%
39.9
41.2
1.51
133
1204
(3003694) ABO and Rh group [Type] in Blood
50
400
1.35
0.97
1.8
1.4
—
—
—
0
0
(4034850)
6
27
2.26
0.94
12.3
9.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
42
1.95
0.90
1.6
1.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
43
1.90
0.88
1.8
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
30
224
1.41
0.87
1.2
1.3
iu/ml
14.2
28.2
0.96
12
68
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
44
1.86
0.87
1.5
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
35
270
1.37
0.85
2.1
2.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
17
114
1.54
0.83
19.9
9.5
mmol/l
-0.9
0.7
0.97
12
93
(3002256) Pathology report gross observation
21
148
1.48
0.82
1.4
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
16
106
1.56
0.82
3.4
6.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
15
98
1.58
0.81
2.3
1.9
g/l
1.4
1.1
0.29
15
88
(3043409) Potassium [Moles/volume] in Arterial blood
0
28
0.00
0.77
0.0
4.8
—
3.8
—
0
23
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
24
2.11
0.75
1.4
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
5
25
2.03
0.73
2.2
4.8
mg/l
23.1
22.7
—
5
14
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
15
101
1.53
0.73
2.5
2.3
au/ml
17.3
16.7
—
5
10
(3004716) Salmonella sp identified in Stool by Organism specific culture
15
101
1.53
0.73
1.3
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
7
41
1.74
0.71
1.0
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
10
61
1.68
0.70
1.3
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
13
189
0.66
0.68
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
111
1018
1.24
0.68
3.5
3.6
pmol/l
14.8
14.6
0.41
105
942
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
7
43
1.65
0.67
1.3
3.0
mmol/l
3.3
3.6
—
7
43
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
126
0.62
0.67
1.1
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
28
1.81
0.66
1.0
4.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
7
44
1.61
0.66
1.1
1.5
u/l
35.1
36.5
—
7
39
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
30
1.69
0.62
2.0
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
30
1.69
0.62
1.2
2.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
64
1.60
0.60
1.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
19
141
1.39
0.59
2.2
2.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
12
81
1.52
0.58
1.3
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
36
296
1.27
0.58
2.4
2.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
39
461
0.80
0.55
1.4
1.5
u/ml
1.0
1.3
—
7
100
(40761535) Cells panel - Urine sediment
13
91
1.46
0.54
11.7
3.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
49
421
1.23
0.54
1.9
1.7
—
—
—
0
0
(3000492) Spirometry study
17
126
1.39
0.54
1.5
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
10
67
1.52
0.51
2.8
3.6
pmol/l
4.9
4.9
—
10
60
(40768804) Tissue Pathology biopsy report
53
463
1.21
0.50
2.4
1.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
27
220
1.27
0.47
1.3
1.3
u/ml
1.3
5.7
—
10
80
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
113
1.36
0.44
2.3
2.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
91
0.65
0.43
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
32
1.58
0.42
2.8
1.5
—
—
—
0
0
(4198724)
0
17
0.00
0.41
0.0
2.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
20
160
1.28
0.41
1.2
1.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
18
0.00
0.40
0.0
1.5
—
13.1
—
0
18
(3035933) Granulocytes/100 leukocytes in Blood
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.7
—
0.5
—
0
14
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
9
69
1.32
0.38
1.7
2.3
ug/l
4.8
4.7
—
9
61
(3021387) Prolactin [Units/volume] in Serum or Plasma
9
70
1.30
0.37
1.4
1.5
mu/l
336.8
323.4
—
9
65
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
87
0.68
0.34
1.2
2.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
30
258
1.20
0.34
2.8
2.7
ug/g
131.7
127.8
0.02
23
214
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
176
0.78
0.34
1.5
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
6
46
1.31
0.33
1.0
2.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
47
1.29
0.32
1.0
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
18
147
1.25
0.32
1.7
2.3
nmol/l
11.2
14.5
1.01
18
138
(3022621) pH of Urine by Test strip
8
63
1.28
0.28
3.6
2.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
71
0.70
0.26
1.6
2.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
12
147
0.80
0.24
1.5
2.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
37
1.36
0.23
1.4
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
37
1.36
0.23
2.2
2.1
—
—
—
0
0
(3020891) Body temperature
5
37
1.36
0.23
24.2
5.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
41
1.23
0.22
2.4
2.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
46
424
1.11
0.22
1.5
1.5
g/l
2.3
2.2
0.04
30
239
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
42
1.20
0.21
1.4
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(4027681)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
15
172
0.86
0.16
2.5
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
22
202
1.10
0.11
3.3
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
14
156
0.89
0.10
1.4
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
14
156
0.89
0.10
1.5
1.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
44
1.14
0.10
1.8
2.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
47
1.07
0.09
6.0
4.6
umol/l
23.2
10.1
—
5
38
(3000764) Benzodiazepines [Presence] in Urine
14
155
0.89
0.09
1.4
2.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
6
58
1.04
0.08
11.8
5.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
14
154
0.90
0.08
1.4
2.0
—
—
—
0
0
(1002224) Polysomnography panel
7
67
1.05
0.08
1.1
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
7
80
0.87
0.07
1.0
1.9
u/l
6.3
7.1
—
7
63
(3023323) Follitropin [Units/volume] in Serum or Plasma
9
85
1.06
0.07
1.0
1.8
iu/l
16.1
15.5
—
9
70
(1761868) Lipid panel - Serum or Plasma
51
495
1.04
0.06
2.7
2.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
123
1219
1.03
0.03
4.2
4.0
mu/l
2.0
1.9
0.61
117
1135
(3019225) pH of Specimen
10
92
1.09
0.03
21.9
5.3
—
—
—
0
0
(3013512) EKG study
27
263
1.03
0.01
3.9
3.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
126
1254
1.02
0.00
4.3
3.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
18
181
0.99
0.00
1.1
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
11
107
1.03
0.00
1.4
2.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
37
367
1.01
0.00
4.4
3.3
ng/l
18.0
33.3
0.76
24
210
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
118
1.02
0.00
1.5
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
115
1.05
0.00
1.2
2.2
—
—
—
0
0
(4010399)
10
95
1.06
0.00
1.3
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
268
1.01
0.00
1.6
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.6
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
4.4
—
2.0
—
0
8
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
77
0.91
0.00
1.3
1.4
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
5.4
—
0
5
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
4.4
—
0
7
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4146454)
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4211845)
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.2
—
57.0
—
0
5
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
22.0
—
0
6
(3027456) Digoxin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.8
—
0.9
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
6.6
—
0
5
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
37.0
—
0.7
—
0
6
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
4.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
4.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
2.5
—
3.9
—
0
6
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
29.2
—
0
6
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
51
0.98
0.00
1.6
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_CONGEN_MALFO_URINARY_SYSTEM and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_OTHER_CONGEN_MALFO_URINARY_SYSTEM.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_CONGEN_MALFO_URINARY_SYSTEM – Other congenital malformations of urinary system
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data